Acura Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US00509L8028
Biotechnology & Medical Research
Sales 2020 | 3.57M 282M | Sales 2021 | 1.56M 123M | Capitalization | 32.54M 2.57B |
---|---|---|---|---|---|
Net income 2020 | -1M -78.86M | Net income 2021 | - 0 | EV / Sales 2020 | 2.91 x |
Net Debt 2020 | 5.86M 462M | Net Debt 2021 | 135K 10.65M | EV / Sales 2021 | 20.9 x |
P/E ratio 2020 |
-5.25
x | P/E ratio 2021 |
-25
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 06/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 28/02/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 28/02/98 |
William Skelly
BRD | Director/Board Member | 73 | 30/04/96 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |